Researcher Profile Statistics: Ramos, António David Rufino
Geo Map
Region
#
NA - North America
34
AS - Asia, other
29
EU - Europe
15
AF - Africa
1
Unknown
2
Total
81
Country
#
US - United States of America
34
CN - China
15
SG - Singapore
12
PT - Portugal
10
DE - Germany
2
HK - Hong Kong
2
IE - Ireland
2
ES - Spain
1
MA - Morocco
1
Unknown
2
Total
81
City
#
Inglewood
12
New York
10
Ashburn
3
Central
2
Dublin
2
Córdoba
1
Rabat
1
Shanghai
1
Tentugal
1
Unknown
48
Total
81
Most viewed items
#
ID: 59074 - Mesenchymal Stromal Cells' Therapy for Polyglutamine Disorders: Where Do We Stand and Where Should We Go?
81
Total
81
Most type viewed
#
ID: all -
81
ID: other -
0
ID: journal -
0
ID: conference -
0
ID: book -
0
ID: thesis -
0
ID: selected -
0
Total
81
Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
Tot
2023
0 0
8 3 0 0
0 0 0 4
11 12
38
2024
13 18
8 4 0 0
0 0 0 0
0 0
43
Ever
81
Geo Map
Region | # |
---|---|
NA - North America | 34 |
AS - Asia, other | 29 |
EU - Europe | 15 |
AF - Africa | 1 |
Unknown | 2 |
Total | 81 |
Country | # |
---|---|
US - United States of America | 34 |
CN - China | 15 |
SG - Singapore | 12 |
PT - Portugal | 10 |
DE - Germany | 2 |
HK - Hong Kong | 2 |
IE - Ireland | 2 |
ES - Spain | 1 |
MA - Morocco | 1 |
Unknown | 2 |
Total | 81 |
City | # |
---|---|
Inglewood | 12 |
New York | 10 |
Ashburn | 3 |
Central | 2 |
Dublin | 2 |
Córdoba | 1 |
Rabat | 1 |
Shanghai | 1 |
Tentugal | 1 |
Unknown | 48 |
Total | 81 |
Most viewed items | # |
---|---|
ID: 59074 - Mesenchymal Stromal Cells' Therapy for Polyglutamine Disorders: Where Do We Stand and Where Should We Go? | 81 |
Total | 81 |
Most type viewed | # |
---|---|
ID: all - | 81 |
ID: other - | 0 |
ID: journal - | 0 |
ID: conference - | 0 |
ID: book - | 0 |
ID: thesis - | 0 |
ID: selected - | 0 |
Total | 81 |
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Tot | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2023 | 0 | 0 | 8 | 3 | 0 | 0 | 0 | 0 | 0 | 4 | 11 | 12 | 38 |
2024 | 13 | 18 | 8 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 43 |
Ever | 81 |